Cargando...

Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?

Tumor necrosis factor (TNF) antagonists have dramatically improved the outcomes of rheumatoid arthritis (RA). Three agents currently available in the USA – infliximab, etanercept, and adalimumab – have been designed to modify the biologic effects of TNF. Infliximab and adalimumab are monoclonal anti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Schwartzman, Sergio, Fleischmann, Roy, Morgan, G James
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2004
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2833457/
https://ncbi.nlm.nih.gov/pubmed/15228615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar1013
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!